| 27.85 -0.96 (-3.33%) | 09-15 16:00 | |||||||||||||
|
|
| Short term | ||||
| Mid term | |
|||
| Targets | 6-month : | 36.79 | 1-year : | 40.24 |
| Resists | First : | 31.5 | Second : | 34.45 |
| Pivot price | 28.79 |
|||
| Supports | First : | 26.72 | Second : | 22.23 |
| MAs | MA(5) : | 27.9 |
MA(20) : | 29.35 |
| MA(100) : | 29.6 |
MA(250) : | 32.21 |
|
| MACD | MACD : | -0.8 |
Signal : | -0.7 |
| %K %D | K(14,3) : | 21.3 |
D(3) : | 15.1 |
| RSI | RSI(14): 44.9 |
|||
| 52-week | High : | 65.29 | Low : | 13.73 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ HIMS ] has closed above bottom band by 32.1%. Bollinger Bands are 37.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 29.19 - 29.35 | 29.35 - 29.5 |
| Low: | 27.43 - 27.6 | 27.6 - 27.76 |
| Close: | 27.6 - 27.88 | 27.88 - 28.13 |
Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.
Tue, 15 Sep 2026
How FTC Data‑Sharing Complaint And Investor Lawsuits At Hims & Hers Health (HIMS) Have Changed Its Investment Story - Yahoo Finance UK
Tue, 15 Sep 2026
Kaplan Fox Class Action Reminder: Hims & Hers Health, Inc. (NYSE - The National Law Review
Tue, 15 Sep 2026
Is Hims & Hers Health Inc (HIMS) a Bargain After 3.3% Drop? GF V - GuruFocus
Tue, 15 Sep 2026
Hims & Hers Health, Inc. (HIMS) Falls More Steeply Than Broader Market: What Investors Need to Know - Yahoo Finance
Tue, 15 Sep 2026
HIMS Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages HIMS Investors with Losses to Contact the Firm - GlobeNewswire
Tue, 15 Sep 2026
Bridging the Perimenopause Information Gap - Hims & Hers Newsroom
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 225 (M) |
| Shares Float | 214 (M) |
| Held by Insiders | 4.9 (%) |
| Held by Institutions | 71.5 (%) |
| Shares Short | 58,670 (K) |
| Shares Short P.Month | 61,410 (K) |
| EPS | -0.64 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.38 |
| Profit Margin | -5.6 % |
| Operating Margin | -12.8 % |
| Return on Assets (ttm) | -2.3 % |
| Return on Equity (ttm) | -32.1 % |
| Qtrly Rev. Growth | 38.2 % |
| Gross Profit (p.s.) | 7.95 |
| Sales Per Share | 11.46 |
| EBITDA (p.s.) | -0.05 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 263 (M) |
| Levered Free Cash Flow | 849 (M) |
| PE Ratio | -43.52 |
| PEG Ratio | 2.5 |
| Price to Book value | 20.03 |
| Price to Sales | 2.42 |
| Price to Cash Flow | 23.77 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |